全文获取类型
收费全文 | 3776584篇 |
免费 | 333730篇 |
国内免费 | 14390篇 |
专业分类
耳鼻咽喉 | 52634篇 |
儿科学 | 120911篇 |
妇产科学 | 98686篇 |
基础医学 | 584964篇 |
口腔科学 | 103707篇 |
临床医学 | 345980篇 |
内科学 | 678728篇 |
皮肤病学 | 99679篇 |
神经病学 | 325397篇 |
特种医学 | 151055篇 |
外国民族医学 | 497篇 |
外科学 | 589883篇 |
综合类 | 114103篇 |
现状与发展 | 91篇 |
一般理论 | 2439篇 |
预防医学 | 315286篇 |
眼科学 | 87972篇 |
药学 | 261780篇 |
22篇 | |
中国医学 | 10178篇 |
肿瘤学 | 180712篇 |
出版年
2021年 | 56397篇 |
2020年 | 37624篇 |
2019年 | 59016篇 |
2018年 | 75010篇 |
2017年 | 57986篇 |
2016年 | 64048篇 |
2015年 | 77817篇 |
2014年 | 114842篇 |
2013年 | 179924篇 |
2012年 | 102245篇 |
2011年 | 102856篇 |
2010年 | 122903篇 |
2009年 | 128228篇 |
2008年 | 89962篇 |
2007年 | 92581篇 |
2006年 | 104094篇 |
2005年 | 98221篇 |
2004年 | 100152篇 |
2003年 | 90074篇 |
2002年 | 79724篇 |
2001年 | 122094篇 |
2000年 | 116024篇 |
1999年 | 112692篇 |
1998年 | 68469篇 |
1997年 | 65773篇 |
1996年 | 63433篇 |
1995年 | 58980篇 |
1994年 | 52836篇 |
1993年 | 49221篇 |
1992年 | 83232篇 |
1991年 | 79814篇 |
1990年 | 76248篇 |
1989年 | 74939篇 |
1988年 | 69704篇 |
1987年 | 68373篇 |
1986年 | 65178篇 |
1985年 | 64971篇 |
1984年 | 56682篇 |
1983年 | 51366篇 |
1982年 | 44830篇 |
1981年 | 41957篇 |
1980年 | 39563篇 |
1979年 | 48991篇 |
1978年 | 40989篇 |
1977年 | 36818篇 |
1976年 | 34105篇 |
1975年 | 32861篇 |
1974年 | 35558篇 |
1973年 | 34219篇 |
1972年 | 31717篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Yuxiang Ma Wenfeng Fang Hongyun Zhao Sai Praneeth Bathena Amol Tendolkar Jennifer Sheng Li Zhang 《The oncologist》2021,26(4):e549-e566
Lessons Learned
- The overall safety profiles of ipilimumab 3 mg/kg and 10 mg/kg administered every 3 weeks, were consistent between Chinese patients with solid tumors in the current study and patients from previous U.S. ipilimumab monotherapy studies. No new safety signals were identified.
- The mean systemic exposures to ipilimumab (assessed by first dose area under the curve during the dosing interval and maximum serum concentration) were numerically lower in the Chinese patient population than in U.S. patients for both 3 mg/kg and 10 mg/kg doses; however, the range of serum concentrations in the Chinese and U.S. populations overlapped (3 mg/kg and 10 mg/kg), suggesting that ipilimumab pharmacokinetics was ethnically insensitive in this study.
52.
53.
54.
Karen Kayser Ariel Washington Lesley M. Harris Barbara Head 《Journal of psychosocial oncology》2021,39(1):17-34
Abstract
Purpose
Financial hardship can be a major cause of distress among persons with cancer, resulting in chronic stress and impacting physical and emotional health. This paper provides an analysis of the lived experience of cancer patients’ financial hardship from diagnosis to post-treatment. 相似文献55.
56.
57.
58.
59.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
60.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment. 相似文献